12:00 AM
Aug 06, 2012
 |  BC Week In Review  |  Clinical News  |  Regulatory

OctaplasLG regulatory update

FDA's Blood Products Advisory Committee will meet on Sept. 20 to discuss a BLA for Octapharma's octaplasLG to...

Read the full 68 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >